Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 5, 2004
(November 5, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its TAXUS™ Express2™ paclitaxel-eluting coronary stent system will be the subject of 15 presentations at...
-
Nov 4, 2004
(November 4, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the CIBC World Markets Fifteenth Annual Healthcare Conference, which is being held November 8-10 in...
-
Nov 2, 2004
and Orlando, FL (November 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced interim results from a 200-patient clinical trial to evaluate the effectiveness, safety and...
-
Nov 2, 2004
and Orlando, FL (November 2, 2004)-- Boston Scientific Corporation (NYSE: BSX) today announced results supporting the efficacy of the Enteryx Procedure in relieving the symptoms of...
-
Nov 2, 2004
and Orlando, FL (November 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its ongoing Enteryx Procedure clinical trial for the treatment of...